Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
6 "Jin Yong Shin"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Malignant disease, Rectal cancer
Short-term and Medium-term Outcomes of Low Midline and Low Transverse Incisions in Laparoscopic Rectal Cancer Surgery
Do Hoe Ku, Hyeon Seung Kim, Jin Yong Shin
Ann Coloproctol. 2020;36(5):304-310.   Published online November 13, 2019
DOI: https://doi.org/10.3393/ac.2019.10.22
  • 4,812 View
  • 98 Download
  • 3 Web of Science
  • 3 Citations
AbstractAbstract PDF
Purpose
Limited data exist on the use of low midline and transverse incisions for specimen extraction or stoma sites in laparoscopic rectal cancer surgery (LRCS). We compared the short-term and medium-term outcomes of these incisions and assessed whether wound complications in specimen extraction sites (SES) are increased by specimen extraction through the stoma site (SESS) in LRCS.
Methods
From March 2010 to December 2017, 189 patients who underwent LRCS and specimen extraction through low abdominal incisions were divided into 2 groups: midline (n = 102) and transverse (n = 87), and perioperative outcomes were compared.
Results
The midline group showed a higher frequency of temporary stoma formation (P = 0.001) and splenic flexure mobilization (P < 0.001) than the transverse group. The overall incisional hernia and wound infection rates in the SES were 21.6% and 25.5%, respectively, in the midline group and 26.4% and 17.2%, respectively, in the transverse group (P = 0.494 and P = 0.232, respectively). In patients who underwent SESS, the incisional hernia and wound infection rates of SES after stoma closure were 39.1% and 43.5%, respectively, in the midline group, and 35.5% and 22.6%, respectively, in the transverse group (P = 0.840 and P = 0.035, respectively).
Conclusion
In terms of incisional hernia and wound infection at the SES, a low midline incision may be used as a low transverse incision in patients without temporary stoma in LRCS. However, considering the high wound complication rates after stoma closure in patients with SESS in this study, SESS should be performed with caution in LRCS.

Citations

Citations to this article as recorded by  
  • Comparison between liquid skin adhesive and wound closure strip for skin closure after subcuticular suturing in single-port laparoscopic appendectomy: a single-center retrospective study in Korea
    Kyeong Eui Kim, Yu Ra Jeon, Sung Uk Bae, Woon Kyung Jeong, Seong Kyu Baek
    Journal of Minimally Invasive Surgery.2024; 27(1): 14.     CrossRef
  • An evidence map and synthesis review with meta-analysis on the risk of incisional hernia in colorectal surgery with standard closure
    C. Stabilini, M.A. Garcia-Urena, F. Berrevoet, D. Cuccurullo, S. Capoccia Giovannini, M. Dajko, L. Rossi, K. Decaestecker, M. López Cano
    Hernia.2022; 26(2): 411.     CrossRef
  • Choice of specimen’s extraction site affects wound morbidity in laparoscopic colorectal cancer surgery
    Mahmood Al Dhaheri, Mohanad Ibrahim, Omer Al-Yahri, Ibrahim Amer, Mahwish Khawar, Noof Al-Naimi, Ayman Abdelhafiz Ahmed, Mohamed Abu Nada, Amjad Parvaiz
    Langenbeck's Archives of Surgery.2022; 407(8): 3561.     CrossRef
Oncologic Outcomes and Risk Factors for Recurrence after Tumor-specific Mesorectal Excision of Rectal Cancer: 782 Cases
Sam Hee Kim, Ki Beom Bae, Jung Min Kim, Jae Ho Shin, Min Sung An, Tae Geun Ha, Sung Mok Ryu, Kwang Hee Kim, Tae Hyeon Kim, Chang Soo Choi, Jin Yong Shin, Minkyung Oh, Seung Hun Baek, Kwan Hee Hong
J Korean Soc Coloproctol. 2012;28(2):100-107.   Published online April 30, 2012
DOI: https://doi.org/10.3393/jksc.2012.28.2.100
  • 3,622 View
  • 22 Download
  • 11 Citations
AbstractAbstract PDF
Purpose

The aim of this study was to analyze the oncologic outcomes and the risk factors for recurrence after a tumor-specific mesorectal excision (TSME) of resectable rectal cancer in a single institution.

Methods

A total of 782 patients who underwent a TSME for resectable rectal cancer between February 1995 and December 2005 were enrolled retrospectively. Oncologic outcomes included 5-year cancer-specific survival and its affecting factors, as well as risk factors for local and systemic recurrence.

Results

The 5-year cancer-specific survival rate was 77.53% with a mean follow-up period of 61 ± 31 months. The overall local and systemic recurrence rates were 9.2% and 21.1%, respectively. The risk factors for local recurrence were pN stage (P = 0.015), positive distal resection margin, and positive circumferential resection margin (P < 0.001). The risk factors for systemic recurrence were pN stage (P < 0.001) and preoperative carcinoembryonic antigen level (P = 0.005). The prognostic factors for cancer-specific survival were pT stage (P < 0.001), pN stage (P < 0.001), positive distal resection margin (P = 0.005), and positive circumferential resection margin (P = 0.016).

Conclusion

The oncologic outcomes in our institution after a TSME for patients with resectable rectal cancer were similar to those reported in other recent studies, and we established the risk factors that could be crucial for the planning of treatment and follow-up.

Citations

Citations to this article as recorded by  
  • Short-term outcomes of robotic tumor-specific mesorectal resection of rectal cancer: surgical techniques in mesorectal division using rolling division of the mesorectum
    Yushi Yamakawa, Nobuhiro Haruki, Nobuo Ochi, Reo Sato, Hiroyuki Asai, Tomohiro Kako, Takumi Kato, Mitsuki Nakazawa, Shuji Takiguchi
    Surgical Endoscopy.2024; 38(6): 3478.     CrossRef
  • Current Controversies in the Management of Locally Advanced Colon Cancer
    Mishal Gillani, Seth Alan Rosen
    The American Surgeon™.2023; 89(8): 3361.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
  • Locally Advanced Rectal Cancer Evaluation by Magnetic Resonance Imaging after Neoadjuvant Therapy on Decision Making: Cancer Center Experience and Literature Review
    Alejandro Recio-Boiles, Hytham Hammad, Krisha Howell, Bobby T. Kalb, Valentine N. Nfonsam, Aaron J. Scott, Hani M. Babiker, Emad Elquza
    Journal of Gastrointestinal Cancer.2020; 51(1): 254.     CrossRef
  • The feasibility of laparoscopic TSME preserving the left colic artery and superior rectal artery for upper rectal cancer
    Chi Zhang, Hao-tang Wei, Wenqing Hu, Yueming Sun, Qinyuan Zhang, Masanobu Abe, Zhuoran Du, Yingying Xu, Liang Zong, Xiang Hu
    World Journal of Surgical Oncology.2020;[Epub]     CrossRef
  • Recurrence in patients with stage I colorectal cancer
    Patrick Ely Teloken, David Ransom, Ian Faragher, Ian Jones, Peter Gibbs, Cameron Platell
    ANZ Journal of Surgery.2016; 86(1-2): 49.     CrossRef
  • Current methods in the treatment of rectal cancer
    L. Yu. Kazieva, E. G. Rybakov, S. I. Sevostianov
    Endoskopicheskaya khirurgiya.2016; 22(4): 49.     CrossRef
  • TRANSANAL TOTAL MESORECTAL EXCISION FOR RECTAL CANCER (review)
    L. Uj. Kazieva
    Koloproktologia.2016; (2): 57.     CrossRef
  • Anastomotic leakage after curative rectal cancer resection has no impact on long-term survival: a propensity score analysis
    Sabrina M. Ebinger, René Warschkow, Ignazio Tarantino, Bruno M. Schmied, Lukas Marti
    International Journal of Colorectal Disease.2015; 30(12): 1667.     CrossRef
  • Determinants of recurrence after intended curative resection for colorectal cancer
    Michael Wilhelmsen, Thomas Kring, Lars N. Jorgensen, Mogens Rørbæk Madsen, Per Jess, Orhan Bulut, Knud Thygesen Nielsen, Claus Lindbjerg Andersen, Hans Jørgen Nielsen
    Scandinavian Journal of Gastroenterology.2014; 49(12): 1399.     CrossRef
  • A Circumferential Resection Margin of 1 mm Is a Negative Prognostic Factor in Rectal Cancer Patients With and Without Neoadjuvant Chemoradiotherapy
    Jong Seob Park, Jung Wook Huh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
    Diseases of the Colon & Rectum.2014; 57(8): 933.     CrossRef
Comparison of Short-term Surgical Outcomes between a Robotic Colectomy and a Laparoscopic Colectomy during Early Experience
Jin Yong Shin
J Korean Soc Coloproctol. 2012;28(1):19-26.   Published online February 29, 2012
DOI: https://doi.org/10.3393/jksc.2012.28.1.19
  • 4,581 View
  • 55 Download
  • 43 Citations
AbstractAbstract PDF
Purpose

Although robotic surgery was invented to overcome the technical limitations of laparoscopic surgery, the role of a robotic (procto)colectomy (RC) for the treatment of colorectal cancer compared to that of a laparoscopic (procto)colectomy (LC) was not well defined during the initial adoption periods of both procedures. This study aimed to evaluate the efficacy and the safety of a RC for the treatment of colorectal cancer by comparing the authors' initial experiences with both a RC and a LC.

Methods

The first 30 patients treated by using a RC for colorectal cancer from July 2010 to March 2011 were compared with the first 30 patients treated by using a LC for colorectal cancer from December 2006 to June 2007 by the same surgeon. Perioperative variables and short-term outcomes were analyzed. In addition, the 30 RC and the 30 LC cases involved were divided into rectal cancer (n = 17 and n = 12, respectively), left-sided colon cancer (n = 7 and n = 12, respectively) and right-sided colon cancer (n = 6 and n = 6, respectively) for subgroup analyses.

Results

The mean operating times for RC and LC were significantly different at 371.8 and 275.5 minutes, respectively, but other perioperative parameters (rates of open conversion, numbers of retrieved lymph node, estimated blood losses, times to first flatus, maximal pain scores before discharge and postoperative hospital stays) were not significantly different in the two groups. Subgroup analyses showed that the mean operative times for a robotic proctectomy and a laparoscopic proctectomy were 396.5 and 298.8 minutes, respectively (P < 0.000). Postoperative complications occurred in five patients in the RC group and in six patients in the LC group (P = 0.739).

Conclusion

Although the short-term outcomes of a RC during its initial use were better than those of a LC (with the exception of operating time), differences were not found to be significantly different. On the other hand, the longer operation time of a robotic proctectomy compared to that of a laparoscopic proctectomy during the early period may be problematic.

Citations

Citations to this article as recorded by  
  • Comparison of Operative Time Between Robotic and Laparoscopic Low Anterior Resection for Rectal Cancer:A Systematic Review and Meta-Analysis
    Zhen Chen, Hua Yu, Huaping Wu, Pingxi Wang, Fanwei Zeng
    Surgical Innovation.2023; 30(3): 390.     CrossRef
  • Comparison of robotic right colectomy and laparoscopic right colectomy: a systematic review and meta-analysis
    Jianchun Zheng, Shuai Zhao, Wei Chen, Ming Zhang, Jianxiang Wu
    Techniques in Coloproctology.2023; 27(7): 521.     CrossRef
  • Robotic versus laparoscopic colorectal surgery in elderly patients in terms of recovery time: a monocentric experience
    Giuseppe Palomba, Vincenza Paola Dinuzzi, Marianna Capuano, Pietro Anoldo, Marco Milone, Giovanni Domenico De Palma, Giovanni Aprea
    Journal of Robotic Surgery.2022; 16(4): 981.     CrossRef
  • Robotic versus laparoscopic left colectomy: a systematic review and meta-analysis
    Leonardo Solaini, Antonio Bocchino, Andrea Avanzolini, Domenico Annunziata, Davide Cavaliere, Giorgio Ercolani
    International Journal of Colorectal Disease.2022; 37(7): 1497.     CrossRef
  • The Senhance Surgical System in Colorectal Surgery: A Systematic Review
    Tyler McKechnie, Jigish Khamar, Ryan Daniel, Yung Lee, Lily Park, Aristithes G. Doumouras, Dennis Hong, Mohit Bhandari, Cagla Eskicioglu
    Journal of Robotic Surgery.2022; 17(2): 325.     CrossRef
  • Comparison of Robotic and Laparoscopic Colectomies Using the 2019 ACS NSQIP Database
    Sara S. Soliman, Joseph Flanagan, Yun Hsiang Wang, Patricia B. Stopper, Rolando H. Rolandelli, Zoltan H. Nemeth
    Southern Medical Journal.2022; 115(12): 887.     CrossRef
  • Laparoscopic versus robotic right colectomy with extra-corporeal or intra-corporeal anastomosis: a systematic review and meta-analysis
    Pietro Genova, Gianni Pantuso, Calogero Cipolla, Mario Adelfio Latteri, Solafah Abdalla, Jean-Christophe Paquet, Francesco Brunetti, Nicola de’Angelis, Salomone Di Saverio
    Langenbeck's Archives of Surgery.2021; 406(5): 1317.     CrossRef
  • Urological and sexual function after robotic and laparoscopic surgery for rectal cancer: A systematic review, meta‐analysis and meta‐regression
    Ian Jun Yan Wee, Li‐Jen Kuo, James Chi‐Yong Ngu
    The International Journal of Medical Robotics and Computer Assisted Surgery.2021; 17(1): 1.     CrossRef
  • Comparison of clinical efficacy of robotic right colectomy and laparoscopic right colectomy for right colon tumor
    Quan Li Zhu, Xin Xu, Zhi Jian Pan
    Medicine.2021; 100(33): e27002.     CrossRef
  • Safety with Innovation in Colon and Rectal Robotic Surgery
    Deborah S. Keller, Christina N. Jenkins
    Clinics in Colon and Rectal Surgery.2021; 34(05): 273.     CrossRef
  • Robotic and robotic-assisted vs laparoscopic rectal cancer surgery: A meta-analysis of short-term and long-term results
    Guojun Tong, Guiyang Zhang, Zhaozheng Zheng
    Asian Journal of Surgery.2021;[Epub]     CrossRef
  • Robotic surgery for colorectal disease: review of current port placement and future perspectives
    Jong Lyul Lee, Hassan A. Alsaleem, Jin Cheon Kim
    Annals of Surgical Treatment and Research.2020; 98(1): 31.     CrossRef
  • The “Micro Hand S” Robot-Assisted Versus Conventional Laparoscopic Right Colectomy: Short-Term Outcomes at a Single Center
    Yijia Zeng, Guohui Wang, Yong Liu, Zheng Li, Bo Yi, Shaihong Zhu
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2020; 30(4): 363.     CrossRef
  • Robotic right colonic resection. Is the robotic third arm a game-changer?
    Alberto Mangano, Federico Gheza, Roberto Bustos, Mario Masrur, Francesco Bianco, Eduardo Fernandes, Valentina Valle, Pier C. Giulianotti
    Minerva Chirurgica.2020;[Epub]     CrossRef
  • Robotic Right Colectomy for Colon Cancer; Two Case Reports
    Ryosuke Fukuyo, Hironobu Baba, Takatoshi Matsuyama, Akifumi Kikuchi, Shinichi Yamauchi, Ayumi Takaoka, Yuriko Matsumiya, Yudai Yamamoto, Masanori Tokunaga, Yusuke Kinugasa
    The Japanese Journal of Gastroenterological Surgery.2020; 53(2): 164.     CrossRef
  • Impact of ASA-score, age and learning curve on early outcome in the initiation phase of an oncological robotic colorectal program
    Hülya Sarikaya, Tahar Benhidjeb, Sergiu I. Iosivan, Theodoros Kolokotronis, Christine Förster, Stephan Eckert, Ludwig Wilkens, Alaa Nasser, Sebastian Rehberg, Martin Krüger, Jan Schulte am Esch
    Scientific Reports.2020;[Epub]     CrossRef
  • Robotic or laparoscopic surgery for rectal cancer - which is the best answer? a comprehensive review of non-oncological outcomes and learning curve
    Sandra L. Kavalukas, Amandeep Ghuman, Stephen P. Sharp, Steven D. Wexner
    Mini-invasive Surgery.2020;[Epub]     CrossRef
  • Right hemicolectomy: a network meta-analysis comparing open, laparoscopic-assisted, total laparoscopic, and robotic approach
    Emanuele Rausa, Michael Eamon Kelly, Emanuele Asti, Alberto Aiolfi, Gianluca Bonitta, Luigi Bonavina
    Surgical Endoscopy.2019; 33(4): 1020.     CrossRef
  • Long-term oncologic after robotic versus laparoscopic right colectomy: a prospective randomized study
    Jun Seok Park, Hyun Kang, Soo Yeun Park, Hye Jin Kim, In Teak Woo, In-Kyu Park, Gyu-Seog Choi
    Surgical Endoscopy.2019; 33(9): 2975.     CrossRef
  • Robotic Versus Conventional Laparoscopic Surgery for Colorectal Cancer: A Systematic Review and Meta‐Analysis with Trial Sequential Analysis
    Ka Ting Ng, Azlan Kok Vui Tsia, Vanessa Yu Ling Chong
    World Journal of Surgery.2019; 43(4): 1146.     CrossRef
  • A standardized suprapubic bottom-to-up approach in robotic right colectomy: technical and oncological advances for complete mesocolic excision (CME)
    Jan Schulte am Esch, Sergio-I. Iosivan, Fabian Steinfurth, Ammar Mahdi, Christine Förster, Ludwig Wilkens, Alaa Nasser, Hülya Sarikaya, Tahar Benhidjeb, Martin Krüger
    BMC Surgery.2019;[Epub]     CrossRef
  • Robotic versus laparoscopic right colectomy: an updated systematic review and meta-analysis
    Leonardo Solaini, Francesca Bazzocchi, Davide Cavaliere, Andrea Avanzolini, Alessandro Cucchetti, Giorgio Ercolani
    Surgical Endoscopy.2018; 32(3): 1104.     CrossRef
  • Short-Term Outcomes with Robotic Right Colectomy
    Scott R. Kelley, Emilie Duchalais, David W. Larson
    The American Surgeon.2018; 84(11): 1768.     CrossRef
  • Robot-Assisted Colectomy for Left-Sided Colon Cancer: Comparison of Reduced-Port and Conventional Multi-Port Robotic Surgery
    Sung Uk Bae, Woon Kyung Jeong, Seong Kyu Baek
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2017; 27(4): 398.     CrossRef
  • Colorectal surgery in elderly patients: our experience with DaVinci Xi® System
    A. Oldani, P. Bellora, M. Monni, B. Amato, S. Gentilli
    Aging Clinical and Experimental Research.2017; 29(S1): 91.     CrossRef
  • Robot-assisted versus laparoscopic-assisted surgery for colorectal cancer: a meta-analysis
    Xuan Zhang, ZhengQiang Wei, MengJun Bie, XuDong Peng, Cheng Chen
    Surgical Endoscopy.2016; 30(12): 5601.     CrossRef
  • Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysis
    Yanlai Sun, Huirong Xu, Zengjun Li, Jianjun Han, Wentao Song, Junwei Wang, Zhongfa Xu
    World Journal of Surgical Oncology.2016;[Epub]     CrossRef
  • Comparison of perioperative and short-term outcomes between robotic and conventional laparoscopic surgery for colonic cancer: a systematic review and meta-analysis
    Sungwon Lim, Jin Hee Kim, Se-Jin Baek, Seon-Hahn Kim, Seon Heui Lee
    Annals of Surgical Treatment and Research.2016; 90(6): 328.     CrossRef
  • Laparoscopic and robot-assisted laparoscopic digestive surgery: Present and future directions
    Juan C Rodríguez-Sanjuán
    World Journal of Gastroenterology.2016; 22(6): 1975.     CrossRef
  • Effect of BMI on Short-Term Outcomes with Robotic-Assisted Laparoscopic Surgery: a Case-Matched Study
    Deborah S. Keller, Nisreen Madhoun, Juan Ramon Flores-Gonzalez, Sergio Ibarra, Reena Tahilramani, Eric M. Haas
    Journal of Gastrointestinal Surgery.2016; 20(3): 488.     CrossRef
  • Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique
    Franco Roviello, Riccardo Piagnerelli, Francesco Ferrara, Maximilian Scheiterle, Lorenzo De Franco, Daniele Marrelli
    International Journal of Surgery.2015; 21: 63.     CrossRef
  • Is robot-assisted laparoscopic right colectomy more effective than the conventional laparoscopic procedure? A meta-analysis of short-term outcomes
    Fabio Rondelli, Ruben Balzarotti, Fabio Villa, Adriano Guerra, Nicola Avenia, Enrico Mariani, Walter Bugiantella
    International Journal of Surgery.2015; 18: 75.     CrossRef
  • Robotic colonic resection
    Emmanouil P. Pappou, Martin R. Weiser
    Journal of Surgical Oncology.2015; 112(3): 315.     CrossRef
  • European association of endoscopic surgeons (EAES) consensus statement on the use of robotics in general surgery
    Amir Szold, Roberto Bergamaschi, Ivo Broeders, Jenny Dankelman, Antonello Forgione, Thomas Langø, Andreas Melzer, Yoav Mintz, Salvador Morales-Conde, Michael Rhodes, Richard Satava, Chung-Ngai Tang, Ramon Vilallonga
    Surgical Endoscopy.2015; 29(2): 253.     CrossRef
  • Robotic versus conventional laparoscopic surgery for rectal cancer: systematic review and meta-analysis
    Seon Heui Lee, Sungwon Lim, Jin Hee Kim, Kil Yeon Lee
    Annals of Surgical Treatment and Research.2015; 89(4): 190.     CrossRef
  • Robot-assisted single-incision total colectomy: a case report
    Yen-Yi Juo, Vincent Obias
    The International Journal of Medical Robotics and Computer Assisted Surgery.2015; 11(1): 104.     CrossRef
  • Robotic versus laparoscopic surgery for colonic disease: a meta-analysis of postoperative variables
    Alberto Zarak, Alvaro Castillo, Kandace Kichler, Lucy de la Cruz, Leonardo Tamariz, Srinivas Kaza
    Surgical Endoscopy.2015; 29(6): 1341.     CrossRef
  • Outcomes of Robotic-Assisted Colorectal Surgery Compared with Laparoscopic and Open Surgery: a Systematic Review
    Chang Woo Kim, Chang Hee Kim, Seung Hyuk Baik
    Journal of Gastrointestinal Surgery.2014; 18(4): 816.     CrossRef
  • Robotic Surgery for Colorectal Cancer
    Ioannis G. Papanikolaou
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2014; 24(6): 478.     CrossRef
  • Robotic versus laparoscopic right colectomy: a meta-analysis
    Huirong Xu, Jianning Li, Yanlai Sun, Zengjun Li, Yanan Zhen, Bin Wang, Zhongfa Xu
    World Journal of Surgical Oncology.2014; 12(1): 274.     CrossRef
  • Outcomes and Costs Associated With Robotic Colectomy in the Minimally Invasive Era
    Joshua A. Tyler, Justin P. Fox, Mayur M. Desai, W. Brian Perry, Sean C. Glasgow
    Diseases of the Colon & Rectum.2013; 56(4): 458.     CrossRef
  • Robotic Colonic Surgery
    Andrew Kai-Yip Fung, Emad H. Aly
    Diseases of the Colon & Rectum.2013; 56(6): 786.     CrossRef
  • Lap Colectomy and Robotics for Colon Cancer
    Eduardo Parra-Davila, Sonia Ramamoorthy
    Surgical Oncology Clinics of North America.2013; 22(1): 143.     CrossRef
Risk Factors of Early Postoperative Small Bowel Obstruction Following a Proctectomy for Rectal Cancer
Jin Yong Shin
J Korean Soc Coloproctol. 2011;27(6):315-321.   Published online December 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.6.315
  • 3,889 View
  • 41 Download
  • 5 Citations
AbstractAbstract PDF
Purpose

Postoperative small bowel obstruction is a common and serious complication following a proctectomy, and early postoperative small bowel obstruction (EPSBO) leads to longer hospital stays, delays chemotherapy in advanced cases, and may be a contributor to mortality. The goal of this study is to identify the risk factors of EPSBO after a proctectomy for rectal cancer, thereby seeking to reduce the incidence of EPSBO.

Methods

Patients (735) who underwent a proctectomy for rectal cancer between March 2005 and February 2010 were entered into this study, and data were collected prospectively. Patients were judged to have EPSBO if, within the first 30 days, they presented symptoms such as nausea, vomiting and abdominal distention lasting for 2 days, and radiologic finding of small bowel obstruction after evidence of return of small bowel motility. The association between EPSBO and patients and surgery-related variables were studied by using univariate and multivariate analyses.

Results

EPSBO developed in 47 cases (6.4%) and was the most frequently occurring complication in the early perioperative period following a proctectomy. The frequency of EPSBO according to operative variables shows that EPSBO developed in 3.0% of the patients who underwent laparoscopic surgery (LS) compared with 8.4% of the patients who underwent open surgery (OS) (P = 0.004). OS (odds ratio [OR], 2.5) and a previous laparotomy (OR, 2.3) were independent risk factors for the development of EPSBO after a proctectomy for rectal cancer.

Conclusion

EPSBO is more likely to occur in patients who undergo OS or who have had a previous laparotomy. LS may be considered as a surgical procedure that can reduce the risk of EPSBO in patients undergoing a proctectomy for rectal cancer.

Citations

Citations to this article as recorded by  
  • Median and medial umbilical ligament repositioning for prevention of pelviperineal complications following abdominoperineal resection—a case series and novel technique
    Anand Thomas, Subi TS, Teena Sleeba, Abhijith Antony, Naveen George
    Langenbeck's Archives of Surgery.2024;[Epub]     CrossRef
  • Establishing and clinically validating a machine learning model for predicting unplanned reoperation risk in colorectal cancer
    Li-Qun Cai, Da-Qing Yang, Rong-Jian Wang, He Huang, Yi-Xiong Shi
    World Journal of Gastroenterology.2024; 30(23): 2991.     CrossRef
  • Optimized machine learning model for predicting unplanned reoperation after rectal cancer anterior resection
    Yang Su, Yanqi Li, Wangshuo Yang, Xuelai Luo, Lisheng Chen
    European Journal of Surgical Oncology.2024; 50(12): 108703.     CrossRef
  • Omental Pedicle Flap Does Not Decrease the Incidence of Bowel Obstruction after Abdominoperineal Resection
    Kunal Kochar, Slawomir Marecik, Leela M. Prasad, John Park
    The American Surgeon™.2016; 82(11): 328.     CrossRef
  • Early Postoperative Small Bowel Obstruction is an Independent Risk Factor for Subsequent Adhesive Small Bowel Obstruction in Patients Undergoing Open Colectomy
    Soo Young Lee, Kyu Joo Park, Seung‐Bum Ryoo, Heung‐Kwon Oh, Eun Kyung Choe, Seung Chul Heo
    World Journal of Surgery.2014; 38(11): 3007.     CrossRef
Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer
Jin Yong Shin, Kwan Hee Hong
J Korean Soc Coloproctol. 2011;27(5):252-259.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.252
  • 3,152 View
  • 27 Download
  • 7 Citations
AbstractAbstract PDF
Purpose

Although nodal metastasis is the most powerful prognostic factor in rectal cancer, marked heterogeneity exists within stage III rectal cancer. Recent studies of rectal cancer have shown a prognostic superiority of the lymph node ratio (LNR) compared with N stage. The purpose of this study was to investigate the prognostic value of the LNR in the era of the 7th edition of the TNM classification.

Methods

We included 190 patients who underwent a curative resection for rectal cancer with nodal metastasis. The patients were divided into four groups on the basis of statistically calculated cut-off values as 0.21, 0.32, and 0.61.

Results

The LNR was an independent risk factor for overall survival (OS; P = 0.008) and for systemic recurrence-free survival (SRFS; P = 0.002). However, the LNR was not a predictive factor for local recurrence. When the N stage of the sixth TNM staging system was separately analyzed as a covariate, the LNR was also found to be a predictive factor for both OS and SRFS (P = 0.012 and P = 0.004, respectively). A LNR value of 0.21 offered the best cut off to separate patients into two prognostic groups.

Conclusion

The defined cut-off values of the LNR were an independent risk factor for OS and distant metastasis-free survival in patients with rectal cancer, irrespective of the sixth or the seventh version of the TNM classification, and the LNR should be considered as a prognostic variable in any future staging system.

Citations

Citations to this article as recorded by  
  • Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis
    Jian Zhou, Zhangyu Lin, Mengyuan Lyu, Nan Chen, Hu Liao, Zihuai Wang, Jianqi Hao, Chunyi Yan, Lunxu Liu
    Japanese Journal of Clinical Oncology.2020; 50(1): 44.     CrossRef
  • Comparison of two novel staging systems with the TNM system in predicting stage III colon cancer survival
    Richard Walker, Trevor Wood, Emily LeSouder, Michelle Cleghorn, Manjula Maganti, Andrea MacNeill, Fayez A. Quereshy
    Journal of Surgical Oncology.2018; 117(5): 1049.     CrossRef
  • The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer
    Chi-Hao Zhang, Yan-Yan Li, Qing-Wei Zhang, Alberto Biondi, Valeria Fico, Roberto Persiani, Xiao-Chun Ni, Meng Luo
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database
    Ben Huang, Chen Chen, Mengdong Ni, Shaobo Mo, Guoxiang Cai, Sanjun Cai
    International Journal of Surgery.2016; 32: 24.     CrossRef
  • Clinical Significance of the Metastatic Lymph-Node Ratio in Rectal Cancer
    Hyoung Chul Park
    Annals of Coloproctology.2013; 29(3): 89.     CrossRef
  • Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Rectal Cancer
    Wafi Attaallah, Omer Gunal, Manuk Manukyan, Gulden Ozden, Cumhur Yegen
    Annals of Coloproctology.2013; 29(3): 100.     CrossRef
  • O índice de linfonodos comprometidos como um preditor para a ocorrência de recidivas tumorais no câncer de cólon estádio III
    Tiago L. Dedavid e Silva, Daniel C. Damin
    Revista do Colégio Brasileiro de Cirurgiões.2013; 40(6): 463.     CrossRef
Review
Colorectal Cancer with Multiple Metastases: Is Palliative Surgery Needed?
Hong-Jo Choi, Jin Yong Shin
J Korean Soc Coloproctol. 2011;27(5):226-230.   Published online October 31, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.5.226
  • 2,913 View
  • 31 Download
  • 1 Citations
AbstractAbstract PDF

In patients with symptomatic incurable metastatic colorectal cancer (mCRC), the goal of resection of the primary lesion is to palliate cancer-related morbidity, including obstruction, bleeding, or perforation. In patients with asymptomatic primary tumors and incurable metastatic disease, however, the necessity of primary tumor resection is less clear. Although several retrospective analyses suggest survival benefit in patients who undergo resection of the primary tumor, applying this older evidence to modern patients is out of date for several reasons. Modern chemotherapy regimens incorporating the novel cytotoxic agents oxaliplatin and irinotecan, as well as the target agents bevacizumab and cetuximab, have improved median survival from less than 1 year with the only available single-agent 5-fluorouracil until the mid-1990s to over 2 years. In addition to significant prolongation of overall survival, combinations of novel chemotherapeutic and target agents have allowed improved local and distant tumor control, decreasing the likelihood of local tumor-related complications requiring surgical resection. Resection of an asymptomatic primary tumor risks surgical complications and may postpone the administration of chemotherapy that may offer both systemic and local control. In conclusion, the morbidity and the mortality of unnecessary surgery or surgery that does not improve quality of life or survival in patients with mCRC of a limited life expectancy should be carefully evaluated. With the availability of effective combinations of chemotherapy and target agents, systemic therapy for the treatment of life-threatening metastases would be a preferable treatment strategy for unresectable asymptomatic patients with mCRC.

Citations

Citations to this article as recorded by  
  • Palliative laparoscopic bowel resection in stage IV colorectal cancer patients with unresectable metastasis
    Kwan Mo Yang, Seok-Byung Lim, Yong Sik Yoon, Chan Wook Kim, In Ja Park, Chang Sik Yu, Jin Cheon Kim
    Korean Journal of Clinical Oncology.2013; 9(2): 134.     CrossRef

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP